ESR1 and cancer: In future work, water-soluble AIEgens with the property of generating reactive oxygen species or with near infrared emission will be conjugated with proteins capable of activating receptor-mediated endocytosis in cancer cells, such as antibodies specific to estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2.